Working... Menu

Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Solid Tumours (START)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03600467
Recruitment Status : Recruiting
First Posted : July 25, 2018
Last Update Posted : September 6, 2018
Information provided by (Responsible Party):
Anthony Joshua, FRACP, St Vincent's Hospital, Sydney

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 30, 2020
  Estimated Study Completion Date : August 30, 2021